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INTRODUCTION: The detection of a second inorganic phosphate (Pi) resonance, a possible 
marker of mitochondrial content in vivo, using phosphorus magnetic resonance spectroscopy (31P-
MRS) at 3T is technically challenging, which may prevent its reproducible quantification.  
PURPOSE: To determine the reproducibility of resting alkaline inorganic phosphate (Pialk) 
measurement using 31P-MRS in human skeletal muscle at 3 tesla (T). METHODS: Resting 31P-
MRS of the quadriceps muscles was acquired on two separate visits, within seven days, in 13 
healthy, sedentary to moderately active young adults using a whole-body 3T MR system. 
Measurement variability related to coil position, shimming procedure, and spectral analysis were 
also quantified. 31P-MRS data were acquired with a 31P/1H dual-tuned surface coil positioned on 
the quadriceps using a pulse-acquire sequence. Test-retest absolute and relative reproducibility 
were analyzed using coefficient of variation (CV) and intra-class correlation coefficients (ICC), 
respectively. RESULTS: Pialk demonstrated a within-subject reproducibility marginally greater 
then the 10% cutoff (CV: 10.6 ± 5.4%; ICC: 0.80), but still appropriate given its small 
concentration in relation to other 31P metabolites. Proximo-distal change in coil positioning along 
the length of the quadriceps induced large variability in Pialk quantification (CV: 21.1%). In 
contrast, measurement variability due to repeated shims on consecutive scans from the same 
muscle sample (CV: 6.6%), and the automated spectral processing procedure, were minor (CV: 
2.3%). Both metrics of absolute and relative reproducibility of Pialk were of similar magnitude to 
other well-resolved metabolites (e.g., phosphocreatine, Pi, and phosphodiester). CONCLUSION: 
Using multiple metrics, the present study established the high reproducibility of Pialk quantification 
by 31P-MRS using a surface coil on the quadriceps muscle at 3T. However, large variability in Pialk 
quantification can originate from positioning the coil on the most distal part of the quadriceps, 
which should be avoided due to shimming inhomogeneity.  
7 
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Since its early development in the 1970’s, phosphorus magnetic resonance spectroscopy (31P-
MRS) has been integral to the study of skeletal muscle bioenergetics. This technique allows 
phosphate metabolites, e.g., adenosine triphosphate (ATP), to be characterized in vivo (see 
representative spectra in Figure 1.) (1–3). A typical 31P-MRS spectrum displays six prominent 
peaks corresponding to the three phosphate groups of ATP, phosphocreatine (PCr), the 
phosphodiesters (PDE) glycerophosphoethanolamine (GPE) and glycerophosphocholine (GPC), 
and inorganic phosphate (Pi), of which the area under the curve provide a measure of metabolite 
Figure 1. A typical 31P MR spectrum of the resting soleus muscle of a healthy young male volunteer. Peak assignments: two signals 
for inorganic phosphate (Pi1: cytosol; Pi2: mitochondrial matrix), the phosphodiesters (PDE) glycerol phosphocholine (GPC) and 
glycerol phosphoethanolamine (GPE), phosphocreatine (PCr), three signals for ATP and pyridine nucleotides (NADPH). As 
excerpted from Kan et al., 2010. 
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concentration. The temporal changes in pH, Pi, and phosphocreatine (PCr) during and following 
an exercise have been extensively used to investigate several key aspects of muscle bioenergetics 
such as ATP turnover rate, proton handling, and mitochondrial function (4–6). Given the central 
role of high-energy phosphate metabolites in bioenergetic processes, 31P-MRS has been essential 
to improving our understanding of skeletal muscle metabolism during the last four decades.  
In recent years, the field of muscle bioenergetics has seen a renewed interest for skeletal 
muscle metabolites with a concentration at the limit of detection of 31P-MRS, such as nicotinamide 
dinucleotide (NAD+) and alkaline Pi resonance (Pialk), given their potential as markers of redox 
balance and mitochondrial content, respectively. In regard to the latter metabolite, in the 1970’s 
(7, 8) and early 1980’s (9–12), researchers first characterized two Pi pools in intact cells and 
mitochondria using high-resolution 31P-MRS at ultra-high fields (>7 Tesla). Specifically, a 
discernible doublet Pi peak could be detected in the MRS spectra, with the upfield (lower 
frequency) peak attributed to the cytosolic compartment (Picyt), and downfield (higher frequency) 
more alkaline peak attributed to the mitochondrial matrix (Pialk) (7, 8, 10, 13–15). The pH of this 
more alkaline Pi pool was indeed consistent with the mitochondrial matrix pH ranges (~7.4 to 8.2) 
(7, 8, 16) measured in vitro and to parallel the changes in mitochondrial volume. Subsequently, 
the observation of two separate pools of Pi was extended to intact perfused cardiac muscle (10, 
13) and rat liver (14, 15).
Recent technological advancements in MR, most notably the development of ultra-high 
field 7T whole-body scanner, which provides higher spectral dispersion and signal-to-noise (SNR) 
ratio (17), has led to a renewed interest in detecting this second alkaline Pi pool in the skeletal 
muscle in vivo(1–3, 18, 19). Kan et al., (2010) were the first to detect Pialk in intact resting soleus 
and tibialis anterior (TA) muscle, which was then confirmed in the quadriceps femoris (2), vastus 
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lateralis muscle (1, 19), and brain (18). Importantly, several results in vivo corroborated the 
original notion of the mitochondrial origin of Pialk. For example, expressed as Pialk/Picyt, a 
significantly lower ratio was documented in the TA (Pialk: 0.07; ~70% slow oxidative fibers) as 
compared to the soleus (Pialk: 0.11; ~90% slow oxidative fibers) (3), thus suggesting a greater 
mitochondrial volume-density in the soleus, consistent with in vitro findings (20, 21). Likewise, 
aerobically trained athletes exhibited a higher Pialk/Picyt ratio (0.07) in the quadriceps muscle than 
recreationally active adults (0.03) (1). Pialk further correlated (r = 0.68) with the maximal rate of 
oxidative ATP synthesis (Vmax) as measured by 31P-MRS in obese-to-sedentary patients (2). Taken 
together, these data suggest that Pialk may be a non-invasive surrogate marker of mitochondrial 
content. 
Despite the far-reaching consequences of using this non-invasive marker for the diagnosis 
of clinical conditions and for the study of human metabolism, several challenges have limited its 
translational impact so far. Only recently (as of 2017) have 7T scanners been approved for clinical 
settings and these MR systems are currently limited to only a few research centers in the world. 
While 3 Tesla MR systems are more widely available, reliably detecting Pialk at this lower magnetic 
field represents a major undertaking, which may explain some of the inconsistencies in the results 
and controversies regarding the origin of the Pialk peak (19, 22, 23). Indeed, the chemical shift 
between Picyt and Pialk is only ~0.4 ppm, and Pialk concentration in the skeletal muscle is <1mM, 
i.e., at the limit of sensitivity of the 31P-MRS technique using standard sequence in vivo, which 
complicates its quantification (3). To date, a reproducible method to quantify Pialk in the skeletal 
muscle using 31P-MRS with a 3T whole-body MR system has yet to be established as it represents 
an important first step toward the translation of this potential surrogate marker of mitochondrial 
content into clinical practice. 
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The goal of this project was to quantify the reproducibility of Pialk measured at 3T by a surface 
coil in the skeletal muscle using a 31P-MRS technique. Specifically, we quantified the within-
subject reproducibility of [Pialk] with a surface coil on the quadriceps using 31P-MRS by calculating 
both the relative and absolute reproducibility of [Pialk] in sedentary to moderately active young 
adults. We also determined the contribution from changes in coil location, shimming procedure, 
and spectral processing by an automated software to the measurement variability of [Pialk].  
1.2 Aims and Hypotheses 
1.2.1 AIM I: To determine the within-subject test-retest absolute and relative reproducibility of 
31P-MRS-derived Pialk at 3T in resting quadriceps muscle of sedentary-to-moderately 
active young adults. 
HYPOTHESIS IA: [Pialk] would demonstrate high absolute (coefficient of variation) and 
relative reproducibility (intra-class coefficient of correlation).  
HYPOTHESIS IB: These metrics would be lower than other well-resolved phosphorus 
metabolites (e.g., PCr, Pi, PDE) detected in the skeletal muscle.  
1.2.2 AIM II: To determine the contribution to [Pialk] measurement variability from changes in 
coil location, repeated shimming, and spectral processing by an automated software 
procedure (CSIAPO). 
HYPOTHESIS IIA: Based upon prior studies (24), we hypothesized that coil location 
would substantially influence [Pialk] reproducibility. 
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HYPOTHESIS IIB: We hypothesized that absolute reproducibility from 10 consecutive 
scans of the same muscle region would be high. 
HYPOTHESIS IIC: We hypothesized high absolute reproducibility from 20 consecutive 




This literature review will first provide an overview of the skeletal muscle mitochondrion. 
Emphasis will be consigned to structural parameters; namely, the primary constituents of the 
energy transduction pathway, membrane phosphatides, and genomic material (mitochondrial DNA 
[mtDNA]). Secondly, using exercise as a physiological stimulus, mitochondrial adaptations will 
be examined within the framework of morphometry. An argument for the importance of reliably 
quantifying mitochondrial content will be put forward. Thirdly, current in vitro surrogates of 
mitochondrial content, and their inherent limitations, will be surveyed. Provided no well-
established in vivo surrogate marker exists, this review will conclude with an inquiry on a novel 
technique, and biomarker, of mitochondrial content: 31P-MRS-derived alkaline inorganic 
phosphate (Pialk), which has been hypothesized to originate from the mitochondrial matrix and 
may represent a promising clinical/research tool in the field of bioenergetics. 
2.2. The Mitochondrion 
2.2.1 The skeletal muscle mitochondrion 
The mitochondrion is commonly depicted as a dynamic, semi-permeable, double-
membrane reticular organelle. A unique mitochondrial inner membrane (IMM) phosphatide, 
cardiolipin, is characterized by its four linoleic acid groups linked by a glycerol backbone 
(resembling two fused phospholipids; see Figure 2.) and is essential to maintain membrane 
integrity and stabilization of complex proteins. The inner mitochondrial membrane (IMM) 
invaginates inwards, creating a distinct pattern of folds called ‘cristae’, that collectively comprise 
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the mitochondrial matrix. Enclosed within the IMM and outer mitochondrial membrane (OMM) 
is the intermembrane space (IMS).  
A composite respiratory chain of multipolypetide enzymes (Complexes I-IV) are 
embedded within the IMM, collectively termed ‘electron transport chain (ETC)’. Adjacent to the 
IMM complex proteins, in the matrix space, is a mitochondrial-exclusive metabolic pathway: the 
‘tricarboxylic acid cycle’ (TCA; Figure 5.). Dehydrogenase activity of TCA enzymes is the source 
of reducing equivalents, which donate electrons at Complex’s I and II. A redox potential across 
ETC proteins, with oxygen (O2) as the final electron acceptor, drives the transmembrane 
electrochemical proton motive force coupled to ATP Synthase (i.e., Complex V) to generate ATP 
by phosphorylation of adenosine diphosphate (ADP) (Figure 3.). 
Figure 2. The structure and location of cardiolipin within the innermitochondrial membrane (IMM). Note its consolidation near 




Figure 3. The structure and function of the electron transport chain (ETC) and tricarboxylic acid cycle (TCA). Note Complex I-IV 
and ATP Synthase driving electron flow and ATP synthesis. Reducing equivalents (NADH and FADH2) from TCA donate electrons 
at Complex I and II, respectively. Oxygen is the final electron acceptor, and a transmembrane proton gradient is established. Note 
the location of TCA in relation to the electron transport chain (ETC). The condensation of Oxaloacetate to Citrate, by Citrate 
Synthase, produces the coenzyme A (CoA) necessary for adequate flux of TCA, and is thus a rate determining enzyme. 
2.2.2 Mitochondrial content  
Mitochondria exhibit morphologic plasticity in response to stressors (e.g., low energy 
levels, hypoxia, exercise, oxidative stress, etc.) and their shapes change continually through the 
combined action of fission, fusion, and motility. Accordingly, mitochondrial function depends on 
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the organelle’s structure, and the organelle’s structure is, in turn, controlled by cell function. 
Research in the field has therefore focused on quantifying ‘mitochondrial content’, which refers 
to the concentration, area occupied, or density, of mitochondria in a given sample volume (e.g., 
tissue biopsy). Mitochondrial density has traditionally been quantified as mitochondrial number or 
fractional area using transmission electron microscopy (TEM) techniques (25). The former is 
simply the number of mitochondria in a given area of myofiber whereas the latter also accounts 
for the mass fraction of the mitochondria, such that increased fractional area can be a product of 
more mitochondria (i.e., number) or larger mitochondria (i.e., volume). Fractional area further 
relates to the three-dimensional reticular nature of the mitochondria governed by dynamic fission 
and fusion machinery (26–29).  
The need for specialized equipment and technical expertise to perform microscopic 
imaging of the mitochondria has fostered the use of alternative surrogate markers of mitochondrial 
content. For instance, spectrophotometric assessment of oxidative enzymes, in particular the TCA 
enzyme citrate synthase (CS) and cytochrome-c oxidase, and other structural components of the 
mitochondrial (e.g., mitochondrial complexes I-V, cardiolipin) and genomic (e.g., mitochondrial 
DNA) machinery have been used in lieu of TEM as mitochondrial markers (30). The diverse 
repertoire of morphometric measurements underscores the importance of reliably quantifying 
mitochondrial content, particularly as this normalization provides important insight into the 
intrinsic properties of the mitochondria. In the context of the present proposal, mitochondrial 
content will refer to mitochondrial fractional area (or volume density). 
2.2.3. Mitochondrial plasticity: training-induced adaptations as a paradigm 
Increased mitochondrial content is a well-established adaptation to aerobic endurance 
exercise training(31–34). For instance, rats subject to chronic aerobic running exhibited a two-fold 
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increase in gluteal m. cytochrome c oxidase (33). This was not muscle specific, as a similar 
magnitude increase in cytochrome c oxidase and succinate dehydrogenase was also documented 
in the gastrocnemius-soleus complex of the same rats. Likewise, in humans, comparative analysis 
of the skeletal muscle of endurance (VO2max: 76.1 ml/kg/min) and recreational (VO2max: 61.3 
ml/kg/min) male athletes revealed a 1.47-fold and 1.20-fold increase in mitochondrial density and 
size, respectively, in endurance athletes (35). Jacobs and Lundby (2013) further characterized the 
training dose-response of mitochondrial content among individuals of different training levels (see 
Figure 4.). Stratified by active (51.2 ± 4.1 ml·kg-1·min-1), well-trained (63.9 ± 4.7 ml·kg-1·min-1), 
highly trained (71.3 ± 1.7 ml·kg-1·min-1), and elite athletes (77.3 ± 3.0 ml·kg-1·min-1), CS activity 
increased as a function of training status. 
2.2.4. Training-induced adaptations to mitochondrial function 
The observation that mitochondrial content increases following exercise is strongly related 
to improvements in mitochondrial function. For example, in the same study by Jacob and Lundby 
(2013), mass specific respiratory capacity significantly increased with training status (see Figure 
5.). ETC capacity, and importantly, maximal state 3 respiration (P), an index of the mitochondria’s 
Figure 4. (A) Aerobic capacity, expressed as relative maximal oxygen consumption (VO2max), across groups. (B) Citrate synthase  
(CS) activity as a biomarker of mitochondrial content across groups. AT, active; WT, well-trained; HT, highly trained; ET, elite. * 
significance of p<0.05. As excerpted from Jacobs & Lundby, 2013. 
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ability to sequentially catalyze redox reactions coupled to ATP synthesis, was superior in the ET 
group and a strong predictor of cardiorespiratory fitness (CRF; see Figure 5A.) 
Relationship between mitochondrial content and function 
Comparative physiology among mammalian species provides a unique perspective on the 
interplay between structure and function, which has led to the formulation of the symmorphosis 
theory (36). Simply, symmorphosis states that in any organism, regulation of the biological units, 
namely, functional and structural parameters, are tightly matched to optimize systemic function. 
Interestingly, using this conceptual framework, mitochondrial volume (Vmt) was closely linked to 
body mass specific VO2max across species (30, 37, 38). Likewise, metabolically superior species 
(defined as having an above average VO2max) within the same size class also exhibit matched 
increase in mitochondrial volume (see Figure 6.). Interestingly, CS activity also correlated 
accordingly with muscle tissue types of differing oxidative profiles, from cardiac (high oxidative 
Figure 5. Mitochondrial respiration control across groups. A: mass-specific respiratory capacity. B: mitochondrial-specific 
respiratory capacity across groups. LN, leak respiration in absence of adenylates; PETF, maximal electron flow through electron-
transferring flavoprotein (ETF) and fatty acid oxidative capacity; PC1, submaximal state 3 respiratory capacity specific to complex 
I; P, maximal state 3 respiration and oxidative phosphorylation capacity; ETS, electron transport system capacity; PC2, submaximal 
state 3 respiratory capacity specific to complex II. Values are means ± SD. Significant difference of *p<0.05, **p<0.01, and 
***p<0.001. As excerpted from Jacobs & Lundby, 2013. 
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capacity; 222 ± 13 µmol·g-1·min-1), skeletal (115 ± 2 µmol·g-1·min-1), and smooth muscle (48 ± 2 
µmol·g-1·min-1) (39).  
Together, these findings suggest that augmented mitochondrial content-volume appears to be 
responsible for the increased tissue-specific aerobic capacity for ATP synthesis. However, upon 
closer inspection, it appears that mitochondrial content and function can sometimes be dissociated, 
thus reflecting intrinsic changes in mitochondrial function. For instance, when normalized to 
mitochondrial content (i.e. CS activity in this study), mitochondrial respiration remained superior 
in elite athletes, suggesting an improved intrinsic capacity for ATP synthesis or “mitochondrial 
quality” (see Figure 5B.) (40). The magnitude of the changes in mitochondrial respiration with 
endurance training is greater than can be expected from the changes in mitochondrial content (41) 
(see Figure 7). Lastly, short-term bed rest result in decreased mitochondrial content, but preserved 
respiration such that intrinsic mitochondrial respiratory capacity is paradoxically increased (42). 
Therefore, the ability to determine the effects of a condition on intrinsic mitochondrial function is 
Figure 6. Whole-body VO2 (A) and allometric plot of VO2 per mitochondrial volume, V(mt), (B) for species ranging in mass from 
16g to 450kg. The open triangles indicate data from humans considering total muscle mass and ‘active’ muscle mass (filled 
triangle). Mb; body mass. As excerpted from Hoppeler & Weibel, 1998. 
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contingent on normalizing to quantitative measures of content. Accordingly, assessments of 
mitochondrial content are imperative to accurately monitor pharmacological and non-
pharmacological treatment interventions. For these reasons, there has been an impetus to identify 
reliable assessment techniques of mitochondrial content.  
2.3. Current assessment techniques of mitochondrial content 
Transmission electron microscopy (TEM), which provides fine resolution structural data of the 
mitochondrial network is considered the “Gold Standard” for the quantitative assessment of 
mitochondrial content (30, 43). However, biological surrogate markers of mitochondrial content 
have been identified and validated. This section will briefly outline methodological considerations 
Figure 7. Mitochondrial respiration and citrate synthase activity in humans of differing training status. SED; Sedentary, ACT; 
Active, TRA; Trained, MT; Moderately-Trained, WT; Well-Trained, HT; Highly-Trained. As excerpted from Bishop et al., 2013. 
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of each assessment technique of mitochondrial content. Finally, a novel in vivo surrogate technique 
will be presented, and a justification for its significance and applicability will be advanced. 
2.3.1 Gold Standard: Transmission Electron Microscopy 
 
The advent of TEM in the early 1940’s was integral for the field of cell biology as the 
intricacies of the cellular structure were being elucidated (44).  
Technical Consideration: TEM exploits the electrochemical properties of electrons. Briefly, short 
wavelength (on the order of 100,000-fold shorter than visible light) electron beams are diffused 
across thin stained cell samples, and the absorptive and scattering characteristics captured to obtain 
contrast image (see Figure 8.) (45). The short wavelength of the electrons with TEM allows for 
fine, subnanometer resolution, optimal for the discrimination of subcellular structures 
(mitochondria) and even intra-mitochondrial structures (i.e., cristae density). Specifically, the 
technique of stereological point counting has been widely utilized to calculate mitochondrial 
Figure 8. Schematic of a standard transmission electron microscopy (TEM) 
technique. Note how short-wavelength electron beams are transmitted 
through a small specimen sample (corresponding to point P) and then 
filtered through a lens. The diffraction and scattering of the electrons is then 
captured on a neighboring imaging plate (corresponding to point R) to 
obtain contrast image as a micrograph. As excerpted from Urban 2008. 
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volume density from TEM-derived micrographs (46). Briefly, an A (length) X B (height) grid is 
superimposed on a two-dimensional image and the intersection of lines defined as a point. 
Therefore, the percentage of mitochondria in a given muscle sample is given by the following 
equation: 
𝑀𝑖𝑡𝑜𝑐ℎ𝑜𝑛𝑑𝑟𝑖𝑎𝑙 𝑃𝑜𝑖𝑛𝑡 𝐼𝑛𝑡𝑒𝑟𝑠𝑒𝑐𝑡𝑖𝑜𝑛𝑠
𝑇𝑜𝑡𝑎𝑙 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑃𝑜𝑖𝑛𝑡𝑠
 
Recently, using a rigorous experimental design, Broskey et al., 2013 demonstrated that a total of 
at least ~100-200 points is necessary to reliably estimate mitochondrial fractional volume, alluding 
to the time-intensive nature of this approach. Representative TEM images of two skeletal muscle 
tissue samples of different mitochondrial volumes are illustrated in Figure 9.  
Specific Limitations: Although 2D-TEM is considered the gold standard technique, it is not 
without limitations. Firstly, it is widely accepted that the mitochondrial network exists as a three-
dimensional structure (27, 29); however, TEM is constrained to two-dimensional cross-sectional 
images. Methodologically, TEM-derived images are confined to small samples (few mg) and 
require the use of fixed in vitro samples, which can be a source of artifacts. Lastly, TEM is time 
intensive, and requires specialized equipment and technical expertise. To circumvent these 
Figure 9. Representative electron microscopy images and western blots of complex I-V. Images and blots are from the two 
subjects with the lowest mitochondrial content (A) and second highest mitochondrial content (B). (C.) Representative image used 
for measuring cristae surface area. A and B are x20,000 magnification; scale bars are 1 µm. C is x80,000 magnification and scale 
bar is 200 nm. White arrows show examples of outer membrane and cristate. As excerpted from Larsen et al., (2012). 
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challenges, other surrogate markers of mitochondrial content have been used in the field of 
mitochondrial physiology. 
2.3.2 Surrogate markers of content 
Citrate Synthase 
Technical Consideration: Citrate Synthase (CS) is a mitochondrial specific enzyme responsible 
for an important, flux determining, catalytic step of the TCA cycle; condensation of acetyl-
coenzyme A (acetyl-CoA) with oxaloacetate (Figure 3.), with the end product citrate (47). TCA is 
the primary source of the reducing equivalents nicotinamide adenine dinucleotide (NADH) and 
flavin adenine dinucleotide (FADH) which provide the electrons and hydrogen ions for the proton 
motive force of ETC. Therefore, by regulating TCA rate, CS indirectly, is responsible for ATP 
synthesis and its activity has become a widely used surrogate marker of mitochondrial content(30). 
Cytochrome-c-oxidase activity, which is considered to be the rate limiting step of the electron 
transport chain, is also sometimes used in lieu of CS activity (33). 
Specific Limitations: Conceptually, CS activity reflects a reaction rate through the Krebs cycle 
and therefore is a functional assay rather than a morphometric index of mitochondrial content. 
Although similar turnover rates for different mitochondrial proteins had originally been observed, 
it has recently been argued that mitochondrial enzymes exhibit independent protein turnover rates, 
with a 5-fold difference in synthesis rate (43). It would therefore be erroneous to extrapolate 
changes in CS activity alone to mitochondrial content. 
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Complex I-V Protein Complexes 
Technical Consideration: Like CS, complex proteins I-V are mitochondrial-exclusive, and both 
their protein expression and activity has been used as surrogate of mitochondrial content (see 
Figure 3.).  
Specific Limitations: Similar to CS, incongruent expression of different mitochondrial complex 
proteins may confound this assessment of mitochondrial content. This is important in light of the 
fact that specific antibodies are used to assay complex proteins, often limited to one or two, while 
complexes are large and composed of multiple distinct proteins.  
Cardiolipin 
Technical Consideration: Cardiolipin (CL) is a mitochondrial-specific, tetra-acyl phospholipid 
located predominantly in the IMM. Its close proximity to ETC proteins allows CL to stabilize 
complex enzymes, even directly participating in proton translocation via cytochrome bc1 
(coenzyme Q:cytochrome c-oxidoreductase or complex III, see Figure 3.), thus maintaining 
respiratory function. At higher respiratory rates, CL facilitates membrane integrity by preventing 
osmatic instability and uncoupling.  
Specific Limitations: CL quantification requires the isolation of Cl from other mitochondrial 
phosphatides, which has posed a challenge to researchers (48). Firstly, with the exception of 
cardiac tissue and isolate mitochondria preparations, CL is proportionally less abundant than other 
phospholipids. Real-time CL detection is further constrained by their lack of conjugated double 
bonds, which require costly and technically difficult mass spectrometry techniques.  
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Mitochondrial DNA (mtDNA) Copy Number  
Technical Consideration: According to the gene dosage theory, the expression of genes is 
proportional to their copy number and thus mtDNA replication is thought to play a key role in 
determining the magnitude of the changes in mitochondrial volume, content, and enzymatic 
activities (49–51). Indeed, mtDNA codes for 13 polypeptides of the ETC; therefore, proteins 
encoded by the mitochondrial genome, to some degree, are independently regulated by mtDNA 
copy numbers (52).  
Specific Limitations: A key limitation of mtDNA is that multiple factors downstream of gene 
expression can influence mitochondrial content (52). Transcription factors independent of gene 
expression have been shown to regulate mitochondrial content. Furthermore, post-translational and 
-transcription control, and the efficiency by which these regulatory pathways function, has been 
implicated in mitochondrial protein and enzyme content. Furthermore, mtDNA copy number 
exhibits marked inter-individual heterogeneity (4-6 copies per cell) which could reduce statistical 
power.  
To illustrate the quantitative differences between these different approaches, Table 1 summarizes 
the magnitude of the changes in mitochondrial content reported by different laboratories in 

















































































Reliability of surrogate markers & common limitations 
A key study by Larsen et al. comprehensively assessed several surrogate markers of 
mitochondrial content; namely, citrate synthase (CS), cardiolipin, and complex I-V protein content 
and activity, and validated their sensitivity with gold standard TEM (30). All data were derived 
from the vastus lateralis muscle of young, healthy males, who represented a large range of aerobic 
exercise capacities (range: 29.9-71.6 ml/min/kg), and likewise, variations in mitochondrial content 
(as determined by fractional area; range: 0.04-0.15 µm2 µm-2). Hence, the heterogeneity of the 
sample population provided adequate statistical power to detect sensitivity across biomarkers.  
Cardiolipin demonstrated the strongest correlation (r = 0.86; p<0.001; Figure 10A.) and 
highest concordance (Rc = 0.85) (within the range of ‘almost perfect’) with TEM, and rivaled CS 
activity. CS demonstrated the second highest correlation (r = 0.84; p<0.001; Figure 10B.) and 
concordance (Rc = 0.80) with TEM. Unlike CS activity and CL, only moderate correlations, and 
concordance deemed ‘substantial’, were documented for Complex I, II, and IV activity and 
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Complex II and V protein content (see Figure 10C-F.). Furthermore, among all markers examined, 
mtDNA exhibited no correlation (r = 0.35; p = 0.23) or concordance with TEM (see Figure 10G.).  
Figure 10. Correlation Plots. Correlation between the relative variation of the mitochondrial content and the 
six biomarkers (A-F) of mitochondrial content that showed the highest Lin’s concordance coefficient (Rc) and 
two biomarkers of certain interest (G and H). Continuous lines represent the perfect linear fit (slope = 1) and 
dashed lines represent the actual linear fit. The linear fit was only shown when significance was present. As 
excerpted from Larsen et al., 2012. 
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Although the aforementioned mitochondrial biomarkers have been validated(30), and are 
structurally and functionally unique, they still share major limitations, primarily derived from their 
in vitro nature. Both TEM and biochemical surrogates require tissue biopsies, which are invasive, 
deterred in clinical settings, and difficult to implement in frail populations (i.e., aging and disease). 
Homogenization, permeabilization, and importantly, fixation procedures, required for enzyme 
assays and TEM, disrupt mitochondrial structural integrity and viability. Accordingly, there is an 
incentive for research into an alternative non-invasive, in vivo surrogate of mitochondrial content. 
2.4 A novel assessment technique of mitochondrial content 
Phosphorus (31P) MRS provides an avenue to study metabolism in intact tissue samples, 
animals, and humans in vivo. The ensuing sections will examine the metabolic data derived from 
31P-MRS in isolated mitochondria, cells, perfused organs, and whole muscle. This review will 
conclude with an inquiry on a novel, in vivo mitochondrial surrogate biomarker: alkaline inorganic 
phosphate (Pialk). 
2.4.1 MRS cell metabolism: MR spectroscopy of skeletal muscle 
Phosphorus magnetic resonance spectroscopy (31P-MRS) is a non-invasive technique that 
provides a unique window into the in vivo biochemistry of tissue by measuring the concentrations 
and turnover rates of high-energy phosphates. Since its first application in skeletal muscle(60), this 
technique has become the cornerstone for the study of muscle bioenergetics and mitochondrial 
function in vivo (61–63). Typical 31P-MRS spectra display six clearly detectable peaks 
corresponding to the three phosphate groups of ATP, PCr, and PDE (see Figure 1.). In resting 
muscle using a relatively long inter-pulse delay (>2-3 s), a well-resolved single inorganic 
phosphate (Pi) signal originating from the cytoplasm can be detected (1–3, 7, 10, 11, 13, 14, 16, 
64). In this condition, Pi is in equilibrium between the mono- and di-protonated forms with an 
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extremely fast chemical exchange between the base and acid forms, such that the Pi signal displays 
a single resonance. 
Interestingly, recent development of the ultra-high magnetic field (>7T) scanner has 
revealed the existence of an alkaline Pi signal (Pialk) in the skeletal muscle of humans, tentatively 
attributed to originate from the mitochondrial matrix (3). Early work in the field of 31P-MRS has 
indeed discriminated an alkaline Pi resonance in isolated mitochondria (8, 16), which later was 
detected in perfused liver (7, 15, 65) and heart extracts (10, 13). For almost two decades, Pialk has 
been largely overlooked in humans, perhaps due to its short longitudinal relaxation time (T1 < 1.5s) 
(3, 8, 14, 16), low concentration (<1 mM), and proximity with the predominant cytosolic Pi peak. 
Although debated (19, 23), other studies conducted at ultra-high magnetic fields have confirmed 
the existence of Pialk in skeletal muscle and further revealed a relationship between [Pialk] and 
dynamic markers of mitochondrial function (1, 2). Accordingly, this metabolite application as a 
potential surrogate biomarker of mitochondrial content has recently garnered attention (66). 
2.4.2 MRS cell metabolism: The pH gradient and pH dependence of Pi 
The semipermeable nature of the IMM to ions, most importantly H+, has provided a unique 
opportunity for researchers to experimentally investigate the origin of the second inorganic 
phosphate resonance peak. The mitochondrial matrix is indeed characterized by a low buffering 
capacity (67), and therefore, mitochondrial pH mainly reflects the balance between proton 
pumping by the respiratory complexes and proton re-entry across ATP synthase (see Figure 3.). 
Specifically, pH is estimated in the range of 7.5-8.2 in isolated mitochondria (68, 69) and 7.4-7.8 
in intact cells (67, 70). In contrast, basal cytosolic pH is more acidic, in the range of ~7.0-7.1 (7).  
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Based upon this established pH gradient between the mitochondrial matrix and cytosol, 
and the pH dependence of the Pi chemical shift, studies have experimentally manipulated 
mitochondrial pH to discriminate the origin of the alkaline inorganic phosphate resonance. Firstly, 
treatment with proton ionophores (e.g., p-trifluoromethoxyphenylhydrazone (FCCP), nigericin) to 
induce proton influx, thereby acidifying the matrix, and abolishing the transmembrane proton 
gradient (i.e., decrease ∆pH), collapsed the second Pi peak at 37 ̊ C in hepatocytes (7) and perfused 
hearts (10, 13) (see Figure 11.). Contrary, treatment with valinomycin, a potassium-ionophore that 
promotes the influx of not only potassium, but also Pi, induces mitochondrial swelling, 
alkalization, and subsequently, splitting of the alkaline and acidic Pi resonances.  
 
Figure 11. Changes in cytosolic and mitochondrial pH in isolated liver cells derived from NMR spectra. The high pH 
resonance is identified as mitochondrial Pi (Open Square); the lower pH resonance is assigned to the cytosolic Pi (Circle). 
Arrows denote the addition of valinomycin, MES buffer, FCCP and the substitution of helium for the O2/CO2 supply at 
the indicated times. The coalescence of the cytosolic and mitochondrial Pi resonances after the cells were de-energised 
by the addition of FCCP and the use of helium is also indicated (Closed Square). As excerpted from Cohen et al., (1978).  
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Secondly, a titration curve of the mitochondrial pH measured by 31P MRS has been 
established in isolated mitochondria (8). The derived pK2 for mitochondrial Pi was ~6.7-6.8 (16), 
a value in accordance with those observed in physiological cell suspension medium using standard 
biochemical techniques (7). Lastly, Durand et al. (1998) in perfused liver, and Garlick et al., (1983) 
in perfused hearts, demonstrated that the chemical shift of this second phosphate peak remained 
unaltered when the cytosolic pH was manipulated through the addition of bicarbonate and CO2 to 
a perfusate. The Pialk resonance shifted rightward, allowing for better discrimination of the 
mitochondrial phosphate resonance, and ruling out the possibility that this second peak originates 
from the extracellular space in their preparation (10, 71). Collectively, these findings provide a 
first set of evidence supporting the ability to detect a Pi pool of mitochondrial origin using 31P-
MRS.  
2.4.3 MRS cell metabolism: The origin of the second peak of phosphate 
A direct consequence of the 31P-MRS studies on intracellular ∆pH was the in vivo 
observation of a splitting of the Pi spectral region. An experimental approach used to identify the 
origin of this second phosphate pool relies on modulating mitochondrial volume by changing the 
experimental temperature condition. Specifically, electron micrographs of rat liver perfused at 
37˚C and 4˚C demonstrated marked mitochondrial swelling at low temperatures (14). The osmotic 
challenge induced by this increase in mitochondrial volume leads to a net influx of phosphate from 
the cytosol to the matrix to maintain the transmembrane ion gradient. Using this approach, a second 
Pi resonance could be detected in the perfused liver samples incubated at 4˚C and 15˚C, which was 
absent at higher physiological temperatures (>25˚C; see Figure 12). Detection of a second Pi 
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resonance in the range of 4-15 ˚C was subsequently confirmed in perfused heart(72), liver(15), 
and isolated liver cells (65). 
Incubation or perfusion with a medium containing valinomycin is another experimental 
approach that has been implemented to discriminate the two phosphate peaks in isolated cell 
preparations and tissues (see Figure 11.). Specifically, valinomycin is a mitochondrial-specific 
potassium (K+) ionophore that amplifies the pH gradient across the mitochondrial membrane (73), 
and thus, the chemical shift difference between cytosolic and matrix Pi resonances. In addition, 
Figure 12. Typical 31P NMR spectra recorded during the thermic transition period from 37 to 4 ˚C. 
Spectra (240 scans) were applied a line broadening of 5 Hz before Fourier transformation. Resonances b1 




this process is associated with a Pi influx in the mitochondria (74) and corresponding mitochondrial 
swelling(65). Using this method, a second phosphate peak was consistently detected in liver cells 
(7), perfused heart (10, 13), and isolated rat liver (65). 
Lastly, in cell suspension, perchloric acid extraction (PCA) has routinely been shown to 
collapse the second Pialk resonance, while the phosphate resonances of solution (in isolated 
mitochondria) (8) or cytoplasm (in perfused cells and organs) were left unperturbed (10, 13). This 
suggests the source of the Pialk resonance to be located in a region perturbed by the processes of 
freeze-clamping and homogenization (10, 13). Although a contribution of exogenous solution Pi 
on the spectral splitting of the phosphate resonance has been argued, its relatively small volume 
(~20%) in the NMR cell, and the fact that pellets were suspended in phosphate-free suspension 
medium, refutes this supposition (7). Collectively, these observations lend support to the 
hypothesis that the alkaline Pi resonance is of mitochondrial origin. 
2.4.4 MRS cell metabolism: Challenges to the measuring alkaline Pi in vivo 
Three primary constituents dictate mitochondrial Pi “visibility” by 31P MRS: (1) total 
concentration of matrix Pi, (2) chemical shift, and (3) spectral line width (16). Since mitochondrial 
Pi accumulates as a function of pH, and Pi is required for ATP synthesis, a significant proportion 
of intracellular Pi is located in the mitochondrial matrix (11, 75, 76). The relatively slow exchange 
rate of Pi (Vmax = 200 nmol/min•mg of mitochondrial protein) between matrix and cytosolic 
compartments eliminates an effect of exchange broadening by Pi spectral peaks coalescing (at least 
at high SNR) (77). Lastly, minimal, to no, effect of paramagnetic species and slow tumbling 
macromolecules, as well as matrix hyperviscosity, on line broadening have been argued (16).  
Nonetheless, some have questioned the ability of 31P-MRS to detect inorganic phosphate 
from the mitochondria. Paramagnetic ions, such as Ca2+ and Mg2+, are densely concentrated in the 
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mitochondria and potentially lead to spectral line broadening (16). Indeed, at supraphysiological 
Ca2+ concentrations (>5 nm/mg of mitochondrial protein), mitochondrial Pi is rendered invisible; 
however, this has been attributed to precipitation, and not T1 or T2 contributions, which represent 
the intrinsic longitudinal relaxation of the Pi net magnetization from which the MR signal is 
acquired. However, within the physiological range of 0.1-0.2 µM in the mitochondria, the effect 
of Ca2+ is trivial. This was also true for Mg2+; at high concentrations, T2 line broadening effects 
rendered matrix Pi invisible, but was insignificant at physiological concentrations (0.1-0.5 nm) 
(16). Therefore, under physiological concentrations of Ca2+ and Mg2+, paramagnetic line 
broadening effects are unlikely to play a role in the invisibility of mitochondrial matrix Pi. 
Indeed, the inability to detect the mitochondrial Pi signal in these earlier studies (9, 75, 78) 
was likely due to T1 differential saturation effects. In perfused hearts, the T1 of cytosolic Pi under 
fast pulsing conditions (9.4 T, wide-bore Bruker WM 360 spectrometer) was 1.0 ± 0.3 seconds 
(10, 13). Under the same experimental condition, the T1 of the mitochondrial Pi resonance was 
qualitatively estimated to be of the order of ~0.5 seconds at 9.4 T (10). This has been quantitatively 
validated by progressive saturation and inversion-recovery experiments in isolated mitochondria 
(T1 = 0.54 secs (16); T1 = 0.60 secs (8)) and perfused liver (T1 = 0.71 (14)) at 9.4 T.  
The significance of relaxation parameters in MRS visibility was further demonstrated in 
studies investigating temperature effects (14, 79). The rational for a ‘temperature-dependency’ 
was proposed on the fact that both longitudinal (T1) and transverse (T2) relaxation times are 
regulated by molecular correlation times, which vary as a function of temperature. Using an elegant 
experimental design, Dufour and colleagues quantified T1 and T2 relaxation times at low (4°C and 
16°C) and high (25°C and 37°C) temperatures in perfused rat livers. Hypothermia (i.e., 4°C) 
induced a considerable line sharpening of the inorganic phosphate resonance, which allowed for 
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discrimination of the doublet Pi peak centered at 2.67 and 2.49 ppm. Importantly, the alkaline 
resonance contribution was absent at 37°C. The T1 value of the main (cytosol) and secondary 
(mitochondria) peak at hypothermia were 1.14 ± 0.24 and 0.71 ± 0.18 seconds, respectively (Table 
3). At higher temperatures, only the cytosolic T1 could be derived, due to coalescence of the 
phosphate peaks. Furthermore, the ability to resolve the mitochondrial Pi resonance, at low 
temperatures (4°C), was well explained by the hypothermia-induced mitochondrial swelling by 
influx of Pi (10, 14).   
2.4.5 MRS cell metabolism: Reproducibility in detecting alkaline Pi at 3T 
Collectively, there is a wealth of evidence suggesting that the mitochondrial Pi signal can 
be detected in vivo by 31P-MRS provided that optimal acquisition parameters, robust processing, 
and spectral quantification are applied. At ultra-high magnetic fields (7 Tesla), the Pialk resonance 
is discernable in resting human skeletal muscle, and further reveals a relationship with a dynamic 
marker of mitochondrial function, such as PCr recovery (1, 2). Nonetheless, the short longitudinal 
relaxation time (T1 < 1.5s) (3, 8, 14, 16) low concentration in resting human skeletal muscle (<1 
mM), and close resonance proximity with the predominant cytosolic Pi peak (~0.4 ppm) present a 
significant challenge to detect Pialk at lower field (≤ 3 Tesla) strengths. Although a lower field 
Table 2. T1 Values of Some Phosphorylated Metabolites of the Excised Rat Liver, Perfused under Various Conditions of 
Temperature. T1 values are in seconds. As excerpted from Dufour et al., 1996. 
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strength inherently reduces SNR, spectral resolution, and therefore, the power to detect Pialk, there 
is merit in such application as a significant proportion of clinical magnets operate at 3T.  
The goal of this project was to quantify the reproducibility of Pialk measured at 3T by a surface 
coil in the skeletal muscle using a 31P-MRS technique. Specifically, we quantified the within-
subject reproducibility of [Pialk] with a surface coil on the quadriceps using 31P-MRS by calculating 
both the relative and absolute reproducibility of [Pialk] in sedentary to moderately active young 
adults. We also determined the contribution from changes in coil location, shimming procedure, 






3.1 Participants Characteristics 
Following informed consent, 13 healthy, sedentary to moderately active, young adults (7 males 
and 6 females) were recruited for this study. Participants were sedentary to moderately active, i.e. 
not participating in structured physical activity more than 3 times a week (documented after 
recruitment by both questionnaire and accelerometry), non-smokers, free from diabetes, and any 
known cardiovascular, peripheral vascular, neuromuscular, or pulmonary diseases. Uniaxial 
accelerometry (GT3X, Actigraph, Pensacola, FL) was used to characterize habitual physical 
activity levels. Briefly, participants were instrumented with an accelerometer during the screening 
and instructed to wear the accelerometer for seven days on their non-dominant hand. The study 
was approved by the Human Research Protection program at the University of Massachusetts 
Amherst. All experimental trials were performed in a thermoneutral environment, at the same time 
of day, with the subjects fasted overnight and no strenuous exercise for the past 24 hrs. 
3.2 Experimental Design 
Assessment of within subject reproducibility: Participants reported to the lab on two separate visits 
spanning a 7-day period (4±2 days). Subjects laid supine within the bore of a 3T MR scanner 
(Skyra, Siemens Medical Solution, Erlangen, Germany) to measure resting concentration in 
phosphorylated compounds and intracellular pH.  
Assessment of potential sources of measurements variability: 
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Protocol 1 “effect of coil position”: In one subject, the coil was moved along the quadriceps  and 
resting metabolites were measured in 6 different locations separated by 4 cm in the distal-to-
proximal direction (Figure 25.). 
Protocol 2 “effect of shimming”: To quantify the measurement variability from repeated shims, 
10 consecutive scans were conducted on the quadriceps of the same participant with the shimming 
procedure reset for each scan. This test was conducted in the morning after an overnight fast. The 
participant remained supine on the bed of the magnet at all times for assessments of coil position 
and shimming procedure.  
Protocol 3 “effect of spectral processing and quantification”: One spectrum randomly selected in 
the dataset was analyzed 20 times using a time-domain fitting routine (80) and the AMARES 
algorithm (81) incorporated into the CSIAPO software (82) and with the same prior knowledge 
for the metabolites of interest.  
3.2.1 Phosphorus Magnetic Resonance Spectroscopy (31P-MRS) 
A custom-built 31P/1H surface circular coil (80 mm single-loop 31P coil surrounded by a 100 mm 
1H coil loop) with linear polarization was positioned above the right quadriceps muscle and tightly 
secured to minimize any displacement. Three-plane scout proton MR images with automatic 























Figure 13. Average and individual full width and half max (FWHM) values for PCr (left) and water (right) for visit 1 and 2. 





















localized map shimming were initially acquired to determine the position of the leg with respect 
to the surface coil. Once visual confirmation of the coil was obtained, a manual localized map 
shimming procedure was performed to reach full width at half maximum (FWHM) of at most 45 
Hz for water (1H; Visit 1: 37.3 ± 5.4 and Visit 2: 37.2 ± 2.8 Hz) and 12 Hz for PCr (31P; Visit 1: 
11.8 ± 0.8 and Visit 2: 11.6 ± 0.6 Hz) (Figure 13). Then, a single 31P MR spectrum was obtained 
with the following parameters: TR=1500 ms, Bandwidth=4000 Hz, 2048 data points, Nominal Flip 
Angle=80, 200 Averages, 1H decoupling WALTZ-4 at 50% i.e., 240 ms, hard pulse 100 s. 
Longitudinal Relaxation (T1) & Repetition Time (TR) 
Radio frequency (RF; designated as the B1 field) pulses perturb the net magnetization (M) 
of 31P nuclei, from which the MRS signal is acquired (Figure 14.). Under fully relaxed conditions, 
M is parallel to the main magnetic field (Bo) in a state of thermal equilibrium. Finely tuned RF 
pulses tip the longitudinal component of M (i.e., Mz) into the transverse plane, and the rate by 
which Mz regrows back to its initial maximum value (Mo) is termed longitudinal relaxation (i.e., 
T1 relaxation). This is an important MRS parameter, as differences in T1 relaxation times between 
phosphorus metabolites (e.g., ATP and Pi), and in the present study, chemical environments (i.e., 
cytoplasm vs. matrix), dictate spectral resolution of higher order multiplets.  
Figure 14. Longitudinal (T1) relaxation time. B0; main magnetic field, M0; net magnetization, Mz; transverse magnetization, B1; 
radio frequency (RF) pulse/magnetic field. Images generated on biorender. 
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T1 relaxation times are conventionally measured using progressive saturation or inverse-
recovery techniques. Initial studies on the mitochondrial origin of Pialk were able to quantify the 
T1 of the cytosolic Pi peak (7, 8), but due to inherent technical limitations, could only qualitatively 
characterize the T1 of the mitochondrial peak (10, 13). Under fast repetition rates (i.e., repetition 
times [TR]), the behavior of Pialk assumed a T1 of half the magnitude of the cytosolic T1, 
quantitatively validated in subsequent studies (3, 11, 16). Indeed, matrix metabolites exhibit 
markedly reduced T1 relaxation(14) (Table 3.) visible only under fast pulsing conditions (i.e., 
lower TR). 
Accordingly, taking into account the T1 characteristics of both phosphate peaks, the present 
study initially sought to optimized TR at 3T. A first set (n=3) of 31P progressive saturation 
experiments was performed (TR=550-2500ms) using an FID (free-induction-decay) pulse 
sequence with a 100µs hard pulse and the following parameters (receiver bandwidth = 4 kHz, 2048 
data points, nominal flip angle=70°, 120 averages per spectrum, 1H decoupling WALTZ-4 at 50%, 
i.e., 240 ms). Due to the very short T1 and specific absorption rate (SAR) limit due to decoupling, 
a second set (n=2) of 31P progressive saturation experiments was performed (TR=300-1500ms) 
without 1H decoupling using the following parameters (receiver bandwidth=4 kHz, 2048 data 
points, nominal flip angle=70°, 120 averages per spectrum) and transmitter frequency set to 1.5 
ppm upfield from the PCr peak. Data from these experiments are presented in Figure 15. The 
apparent T1 of Pialk was 412 ± 112 ms. 
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Figure 15. Progressive saturation experiments at TR ranging from 550-2500ms using an FID (free-induction-decay) pulse sequence 
with a 100µs hard pulse and the following parameters (receiver bandwidth: 4 kHz, 2048 data points, nominal flip angle: 70°, 120 
averages per spectrum, 1H decoupling WALTZ-4 at 50%, i.e., 240 ms). A. Signal intensity and B. Signal to noise ratio (SNR )at 
different repetition times. n = 5. 
Nominal Flip Angle 
T1 relaxation is dictated, among other factors, by the magnitude of the rotational 
displacement experienced by M following the application of an RF pulse; known as flip angle 
(Figure 15A.). Given an RF pulse with a flip angle of ɑ, the transverse component of M (i.e., Mx,y) 
is given by the equation Mosin(ɑ), and the longitudinal component (i.e., Mz) by the equation 
Mocos(ɑ). Since the MR signal is largely a function of Mx,y, one can see that stronger signals are 
produced at larger flip angles, i.e., given ɑ = 90°, all of Mz is converted to Mx,y with a maximum 
value of Mo. 
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Nonetheless, when optimizing the flip angle, it is imperative to account for MR sequences 
with repetitive RF pulses, where TR influences both T1 relaxation and MR signal strength. If TR 
is sufficiently long, on the order of > 4-5x the T1, then Mz will adequately recover to Mo. 
Accordingly, under these conditions, a 90° flip angle would generate the most significant signal. 
However, in the present study, a series of repetitive RF pulses at short TR (to account for the short 
T1 relaxation of Pialk) would preclude the application of 90° flip angles. The rational is based on 
insufficient relaxation of Mz to Mo, establishing a new steady-state longitudinal magnetization 
(Mss) on the order of Mss < Mo, an NMR phenomenon known as partial saturation. 
A series of partial flip angles (<90°), thus, would create an appreciable transverse 
magnetization while largely preserving the longitudinal magnetization. The Mss would be 
minimized, as would signal loss from the partial saturation effects. The strength of the MR signal, 
therefore, is a fine balance between optimal flip angles and sufficient transverse magnetization. To 
maximize the MR signal in the present study, while minimizing partial saturation effects, nominal 
Figure 16. Effect of flip angle on signal intensity in the skeletal muscle at 3T (receiver bandwidth: 4 kHz, 2048 data points,120 
averages per spectrum, 1H decoupling WALTZ-4 at 50%, i.e., 240 ms). A. Framework of the flip angle (images generated in 
biorender). B. Signal intensity at flip angles of 50-90° in the present study. n = 5. 
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flip angle was optimized in accordance with the fast-pulsing conditions necessary to discriminate 
the small mitochondrial inorganic phosphate peak (see Figure 16B.). 
Proton (H+) Decoupling and pulse duration 
A common phenomenon in 31P-MR spectroscopy is the splitting of spectral peaks into 
higher order multiplets. Formally known as j-coupling, spectral line-splitting is the result of 
electron-mediated interactions between two neighboring nuclear spins residing within the same 
molecule. This is the case for the current phosphate doublet, which is a unique type of 
heteronuclear j-coupling between chemically distinct 31P and 1H nuclei. Contraire to homonuclear 
j-coupling (between adjacent 31P nuclei, e.g., ATP), where the coupling constant (spacing between 
sub peaks in a multiplet) is large and allows for discrete line separation, heteronuclear j-coupling 
is subtle, and often results in a broadening of spectral lines. Specifically, Pialk has a spectral peak 
separation of 0.4 ppm, or ~20 Hz at 3T, with the adjacent larger Pi peak. 
Consequently, the technique of proton decoupling has been widely implemented to 
improve spectral resolution of heteronuclear-coupled phosphorus signals. Briefly, application of 
Figure 17. Progressive saturation experiments at TR ranging from 550-2500ms using an FID (free-induction-decay) pulse sequence 
with a 100µs hard pulse and the following parameters (receiver bandwidth: 4 kHz, 2048 data points, nominal flip angle: 70°, 120 
averages per spectrum, 1H decoupling WALTZ-4 at 50%, i.e., 240 ms). A. Signal intensity at varying decoupling durations. B. 
Signal intensity at different pulse durations. n = 3. 
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finely tuned RF-irradiation at the 1H Larmor Frequency uncouples the 1H nuclei reference state 
from the 31P cohort. The effect is instantaneous and useful at ≤ 3T where line widths are in the 
order of the j constants (< 7 Hz). Current proton decoupling techniques are broadband, which 
incorporate a series of short composite pulses phase-cycled to disrupt the 1H resonance. 
Accordingly, the present study implemented a wideband alternating-phase low-power technique 
for zero-residual-splitting (WALTZ-4) at 50% i.e., 240 ms, hard pulse=100 s, which has been 
optimized for limited specific absorption rate (SAR) and use in conjunction with surface-coils 
(Figure 17.). 
Surface Coils 
As cited in a previous section, the first applications of 31P MR spectroscopy were in isolated 
cells, tissues, and much later, perfused organs, i.e., in vitro. Translation to in vivo human skeletal 
muscle was initially not feasible given technological constraints of early MRS; namely, limited 
bore size83 and spatial discrimination84. Although the advent of large-bore superconducting 
systems facilitated studies in the intact human, the large volume of skeletal muscle (relative to 
tissues) presented issues of heterogeneity, not suitable for spectroscopy. Consequently, the 
development of surface coil to spatially localized 31P-MRS was a major advance in the field for 
the study of skeletal muscle metabolism (84). 
Standard surface coils are positioned in close contact to the muscle of interest to detect 
phosphorus signals from the tissue underneath (84). Often in the shape of small circle, the design 
of these coils allows for the quantification of data in a known volume of interest without 
contamination from neighboring tissue. The signal sensitivity of standard surface coils is roughly 
proportional to the coil’s diameter, and therefore, provides high spatial and signal sensitivity to 
surface tissue as illustrated in Figure 1885. Importantly, this feature avoids contamination from 
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deeper structures and allows for spatially selective measurement of metabolites. Accordingly, the 
high signal sensitivity and spatial signal localization offered by surface coils were well suited for 
our study design, and 31P-MRS data were acquired with a dual tuned 31P-proton (1H) custom-made 
surface coil with linear polarization positioned above the quadriceps (largely superficial muscles 
that includes the rectus femoris). The 31P single-loop coil diameter was 80 mm which was 
surrounded by the 100 mm 1H coil loop (Stark Contrast, Germany) thus allowing for a signal 
localization depth of approximately ~4 cm in the muscle. 
 
  
Figure 18. Illustration of surface coil signal sensitivity. Measured B1 amplitude in the median sagittal slice with a surface 
coil. Black dashed boxes denote the position of the phantom. Relative positions are in cm. The greater B1 magnitude indicates 





To assess measurement reproducibility of Pialk in the quadriceps muscle, we quantified 
measurement variability due to spectral processing by automated software (CSIAPO) (86). Raw 
data (FID before Fast Fourier Transformation [FFT], Figure 20.) were imported into CSIAPO and 
the spectra auto-populated. The first step in spectral processing was to establish an even baseline 
Figure 19. Representative spectrum acquired at repetition time [TR]: 1500 ms, Bandwidth (BW): 4000 Hz, 2048 data points, 
Nominal Flip Angle (FA): 80°, 200 Averages, 1H decoupling WALTZ-4 at 50% i.e., 240 ms, hard pulse 100 µs. A. Spectrum not 
corrected for zero order PHASE adjustment. B. Spectrum corrected for zero order PHASE adjustment only. For Panel A., peak at 
20 ppm is a phantom. Highlighted in Panel B. is the Pi peak with the alkaline peak upfield. 
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for the PCr peak, which was accomplished by adjusting the Zero Order Time PHASE using both 
‘gross’ and ‘fine’ adjustment parameters (Figure 19.).  
  




Figure 21. Representative spectrum acquired at repetition time [TR]: 1500 ms, Bandwidth (BW): 4000 Hz, 2048 data points, 
Nominal Flip Angle (FA): 80°, 200 Averages, 1H decoupling WALTZ-4 at 50% i.e., 240 ms, hard pulse 100 µs. A. Spectrum not 
corrected for first order PHASE adjustment. B. Spectrum corrected for first order PHASE adjustment. C. Spectrum with PCr 




Secondly, a First Order Time PHASE adjustment of the ß-ATP peak was performed. The goal 
with the First Order Phase adjustment is to align the ß-ATP peak with the 0 baseline, making 




Figure 22. Representative spectrum acquired at repetition time [TR]: 1500 ms, Bandwidth (BW): 4000 Hz, 2048 data points, 
Nominal Flip Angle (FA): 80°, 200 Averages, 1H decoupling WALTZ-4 at 50% i.e., 240 ms, hard pulse 100 µs. A. The green line 
represents the estimate fitting of the sequence. Note the marked splitting of the inorganic phosphate peak (second peak to the left 
of the PCr peak), evidence that our fitting parameter could detect both Pi peaks. B. Residuals associated with the fitting procedure 
in yellow lines. 
After phase correction, the spectral frequency is adjusted using PCr as the reference (-2.45 
ppm) to account for potential variation in carrier frequency. Lastly, to improve spectral quality and 
splitting of the Pialk resonance from the main resonance Pi, a 2Hz Gaussian filter was applied on 
all spectra based on preliminary work. 
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The spectra were then fitted using AMARES and a priori information of the metabolites 
of interest (PME, Pialk, Picyt, PDE, PCr, ATP-α,γ,β (Figure 22.). 12 Lorentzian resonances were 
defined as a priori information to AMARES. The fitting constraints were frequency range, fixed 
phase, amplitude, decay 
Statistics 
Test-retest absolute and relative reproducibility were analyzed using within-subject 
coefficient of variation (CV) and intra-class correlation coefficients (ICC), respectively, as 
described previously (87). Relative reproducibility is related to an individual maintaining his/her 
position, e.g., rank, within a sample with repeated measurements (88). We assessed this type of 
reproducibility with the ICC, a two-way random effects model with single measurement 
reproducibility in which variance over the repeated sessions is considered. The ICC indicates the 
error in measurements as a proportion of the total variance in scores. According to Atkinson & 
Nevill (1998), the following criteria are recommended to qualitatively characterize relative 
reproducibility as assessed by the ICC: ICC = 0.7-0.8 as ‘questionable’, ICC = 0.8-0.9 as ‘good’, 
and an ICC > 0.9 as ‘high’ (88). Nevertheless, like the Pearson’s r, an ICC close to 1 indicates 
‘excellent’ reproducibility. 
Absolute reproducibility is the degree to which repeated measurements vary for individuals 
and the measurement system88. This was performed by calculating the within subject CV (i.e., 
test-retest) and measurement procedure (i.e., coil positioning, repeated shims, automated spectral 
processing), and then reporting the mean CV for the respective dependent variables. Accordingly, 
the within subject CV was calculated as the SD of the measurements recorded during both visits, 
or for each scan, and then divided by the mean of the two visits as previously described (87). This 
assessment of CV is different from the intersubject that quantifies the variability within the group 
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rather than the variability within subjects that requires a repeated measurement design. A CV of ≤ 
10% was deemed ‘excellent’ (88). The corresponding result was expressed as a percentage. ICC 
and CV analysis were done using a downloadable spreadsheet (87). Results are presented as means 






Baseline subject characteristics (males = 7; females = 6), including anthropometric, physical 







 Total (N=13)* Total (N=13)# Males (n=7) Females (n=6) p-value 
Age (yrs.) 22 ± 3 22; 18-29 22 ± 4 22 ± 3 0.63 
Height (cm) 172.9 ± 9.7 170.5; 163-192 178.6 ± 8.7 164.8 ± 2.1 0.01 
Mass (kg) 70.5 ± 12.8 68.3; 51.1-91.3 76.2 ± 12.5 62.4 ± 8.6 0.05 
BMI (kg/m2) 23.6 ± 3.6 23.3; 17.51-29.14 24.0 ± 4.1 23.0 ± 3.2 0.64 
MVPA (min/day) 175 ± 180 119; 52.38-218 211 ± 242 134 ± 59 0.47 
Step Counts 7812 ± 2432 7060; 3764-13,812 7192 ± 903 8535 ± 3472 0.34 
Hemoglobin (g/dl) 14.26 ± 1.78 14.7; 12.3-17.3 15.80 ± 1.19 13.02 ± 0.97 0.01 
Hematocrit (%) 42 ± 5 42; 37-50 46 ± 3 38 ± 2 0.81 
Glucose (mg/dl) 87.27 ± 3.69 88; 80-93 85.00 ± 3.46 89.17 ± 2.86 0.06 
Cholesterol (mg/dl) 176.40 ± 33.78 182.5; 116-225 160.00 ± 18.87 187.33 ± 38.50 0.23 
HDL (mg/dl) 59.20 ± 15.13 54; 42-86 48.75 ± 6.40 66.17 ± 15.56 0.07 
LDL (mg/dl) 102.60 ± 22.73 112; 55-125 95.75 ± 17.29 107.17 ± 26.23 0.47 
Triglycerides (mg/dl) 72.30 ± 18.52 75; 40-95 76.75 ± 16.46 69.33 ± 20.70 0.57 
*Values are expressed as mean ± SD 
#Values are expressed as median; range 
BMI: Body Mass Index; MVPA: Moderate-Vigorous Physical Activity; HDL: High Density Lipoproteins; LDL: Low Density 
Lipoproteins  
Table 3. Subject characteristics 
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4.2 Test-Retest Reproducibility of Pialk and Phosphate Metabolites  
Pialk (CV=10.6 ± 5.4%) and Pialk/Picyt (CV=10.3 ± 8.1%) demonstrated an absolute 
reproducibility close to the 10% cut-off deemed appropriate for excellent reproducibility. Relative 
reproducibility, as assessed by the ICC, was ‘very good’ (ICC=0.80 [0.80,0.804]) and ‘good’ 
(ICC=0.71 [0.71,0.708]) for Pialk and Pialk/Picyt, respectively (Table 4.; Figure 23., 24.). 
Accordingly, individual data for both Pialk and Pialk/Picyt were close to the line of identity, i.e., a 
reference line (y=x) comparing two separate data sets expected to be identical, and with a 
homogeneous distribution around the line further confirming the high reproducibility of the 
quantification of these metabolites (Figure 23., 24.). 
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Table 4. Within-subject reproducibility in 31P-MRS variables at rest 
Resting Metabolite Visit 1 Visit 2 Mean CV (%) ICC (95% CI) 
PCr (mM) 37.2 ± 3.1 36.9 ± 3.1 3.3 ± 2.2 0.77 (0.77,0.768) 
Pi (mM) 3.6 ± 0.7 3.5 ± 0.6 5.9 ± 4.4 0.84 (0.84,0.837) 
Pialk (mM) 0.35 ± 0.09 0.35 ± 0.10 10.6 ± 5.4 0.80 (0.80,0.804) 
PDE (mM) 1.80 ± 0.42 1.68 ± 0.42 5.7 ± 5.7 0.94 (0.94,0.936) 
Total NAD (mM) 1.11 ± 0.23 1.31 ± 0.32 14.4 ± 0.2 0.23 (0.23,0.231) 
Pialk/Picyt 0.10 ± 0.03 0.10 ± 0.03 10.3 ± 8.1 0.71 (0.71,0.708) 
β-ATP (a.u.) 65431 ± 14522 60322 ± 20330 11.4 ± 29.6 0.41 (0.41,0.409) 
pH Cytosolic 6.97 ± 0.02 6.97 ± 0.02 0.1 ± 0.1 0.64 (0.64,0.640) 
pH Mitochondrial 7.46 ± 0.03 7.44 ± 0.03 0.2 ± 0.1 0.74 (0.74,0.745) 
*Values are expressed as mean ± SD 
CV = coefficient of variation, CI = 95% lower and upper confidence intervals 




PDE exhibited ‘excellent’ absolute (CV: 5.7 ± 5.7%), and ‘very good’ relative (0.94 
[0.94,0.936]), reproducibility (Table 4, Figure 23.). However, a systematic bias between visit 1 
(1.80 ± 0.42 mM) and 2 (1.68 ± 0.42 mM) was detected as illustrated by the large proportion of 
[PDE] values below the line of identity (Figure 23.). Total NAD (NADH+NAD) demonstrated an 
absolute reproducibility (CV=14.4%) lower than Pialk and PDE, with also “poor” relative 
(ICC=0.23) reproducibility (Table 4 and Figure 25.). 
   
Figure 23. Top three panels represent the means and individual data for Pialk, PDE, and PCr. Scatter plot of Pialk, PDE, and PCr 
comparing visit 1 and visit 2. Dashed line represents the ‘line of identity’. 













































































































Phosphate metabolites with a greater resolution and signal intensity than Pialk and PDE, 
PCr (CV = 3.3 ± 2.2%; ICC=0.77 [0.77,0.768]) and Pi (CV = 5.9 ± 4.4; ICC=0.84 [0.84,0.837]), 
demonstrated ‘excellent’ and ‘moderate’ to ‘very good’ absolute and relative reproducibility 
respectively (Table 4; Figure 23., 25.) 
Figure 24. Mean and individual data for the ratio of Pialkaline and Picytosolic (left). Scatter plot of the ratio of Pialkaline and Picytosolic 
comparing visit 1 and visit 2. Dashed line represents the 'line of identity'. 






















































Lastly, both the ‘acidic’ cytosolic pH (CV: 0.1 ± 0.1%) and alkaline ‘mitochondrial’ pH 
(CV: 0.2 ± 0.1%) demonstrated the highest absolute reproducibility of all measurements acquired 
(Table 4 and Figure 25.). However, their relative reproducibility was ‘poor’ (ICC < 0.7).  
 
  



































































Figure 25. Means and individual data for inorganic phosphate (Pi), total nicotinamide adenine dinucleotide (NAD+NADH), and 
cytosolic and mitochondrial pH 
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4.3 Effect of coil location on Pialk quantification 
The between-sites coefficient of variation for Pialk was 21.1% (Table 5, Figure 26.). When sites 1 
and 2 were excluded from the analysis, the CV for Pialk between sites decreased to 7.9%. The other 
phosphate metabolites (PCr, Pi, β-ATP and PDE) exhibited a similar pattern with higher 
concentrations at sites 1 and 2 (Table 5.) The total phosphate signal was not different along the 
length of the thigh (Table 5). However, the full width half maximum of PCr was substantially 
higher at site 1 and 2 (Table 5).   
Figure 26. Pialk concentrations across the six different sites (left). The six different ‘sample volumes’ were measured along the 
longitudinal length of the quadriceps, in 4 cm intervals, starting at the patella and with the muscle fully relaxed (right). FWHM: 
Full Width Half Maximum of PCr. 
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Table 5. Measurement Variability in Pialk and Phosphate Metabolite Quantification due to Coil Placement 
 
 
Sample Location Pialk (mM) PDE (mM) Pi (mM) PCr (mM) β -ATP Sum 
Site 1 0.55 2.46 3.4 31.9 76900 368810 
Site 2 0.46 2.37 3.3 32.0 84000 399570 
Site 3 0.33 2.14 2.8 29.5 89500 388360 
Site 4 0.38 2.10 2.9 29.0 89200 383880 
Site 5 0.38 2.16 3.0 30.5 79300 357510 
Site 6 0.33 2.00 2.9 28.9 78300 333970 
Coefficient of Variation (%) 21.06 % 7.93 % 8.1 % 4.6 % 6.7 % 6.4 % 
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4.4 Effect of repeated shimming on Pialk Quantification 
Pialk demonstrated ‘excellent’ absolute reproducibility (CV: 6.6 %) (Table 6.). Likewise, and as 
expected, PCr (CV: 1.5%), Pi (CV: 3.0%), and PDE (CV: 1.7%) all demonstrated ‘excellent’ 
absolute reproducibility. 
4.5 Effect of spectral processing on Pialk and phosphate metabolites reproducibility 
Pialk demonstrated excellent absolute reproducibility (CV: 2.3 %) (Table 6.). Likewise, PCr (CV: 






 PCr (mM) Pi (mM) Pialk (mM) PDE (mM) pH Cyto pH Mito 
a. Effect of coil positioning (n=6 measurements) 
Metabolic variable 
(% CV) 
30.3 ± 1.4 
(4.6) 
3.1 ± 0.2 
(8.1) 
0.40 ± 0.09 
(21.1) 
2.21 ± 0.18 
(7.9) 
7.01 ± 0.01 
(0.1) 
7.49 ± 0.04 
(0.5) 
b. Within-session reproducibility (n=10 measurements) 
Metabolic variable 
(% CV) 
29.1 ± 0.4 
(1.5) 
3.0 ± 0.1 
(3.0) 
0.40 ± 0.03 
(6.6) 
2.19 ± 0.04 
(1.7) 
6.99 ± 0.00 
(0.1) 
7.44 ± 0.02 
(0.3) 
c. Reproducibility of spectral processing (n=20 measurements)  
Metabolic variable 
(% CV) 
32.2 ± 0.2 
(0.7) 
2.7 ± 0.0 
(0.7) 
0.37 ± 0.01 
(2.3) 
1.19 ± 0.01 
(0.9) 
6.98 ± 0.00 
(0.0) 
7.43 ± 0.00 
(0.0)  
Values are expressed as mean ± SD, with the coefficients of variation (CV) in parentheses.  






The aim of the present study was twofold: (1) to quantify the test-retest absolute and relative 
reproducibility of 31P-MRS-derived Pialk at 3T in resting quadriceps muscle of healthy young 
adults; and (2) to determine the contribution to [Pialk] measurement variability from coil placement 
and repeated shims within the same session, as well as spectral processing using an automated 
software procedure86. Although greater than the 10% cut-off for ‘excellent’ absolute 
reproducibility, a test-retest CV of 10.6% is still consistent with our hypothesis of acceptable 
reproducibility. Importantly, ‘excellent’ reproducibility from within-session repeated shims and 
spectral processing was reported for Pialk in the present study. Test-retest variability of Pialk was 
two-fold greater than other well-resolved metabolites in the 31P spectrum, such as PCr, Pi, and 
PDE. Coil location affected Pialk quantification, with higher [Pialk] in the distal region of the thigh 
33% of femur length) caused by magnetic field inhomogeneity in the sampled area. Consecutive 
scans within the same day with repeat of the shimming procedure resulted in smaller Pialk 
variability (CV=6.6%) than within-subject reproducibility during a 3-7 day period (CV=10.6%). 
Finally, the automated spectral processing procedure was highly reproducible even for Pialk (CV ≤ 
2.3%). Collectively, the present study supports the reproducibility of Pialk quantification by 31P 
MRS using a surface coil on the quadriceps at 3T, provided as long magnetic field homogeneity is 
sufficient (FWHM of PCr < 12.5 Hz).  
5.1 Test-retest absolute reproducibility of high-energy phosphate metabolites by 31P-MRS  
Consistent with our initial hypothesis, a central finding of the present study was the 
documentation of an acceptable absolute reproducibility (CV = 10.6 ± 5.4%; marginally greater 
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than the 10% cut off for ‘excellent’ reproducibility) and “good” relative reproducibility (defined 
as an ICC ranging from 0.80-0.90) for [Pialk]. Likewise, PCr, Pi, PDE, and ATP- β demonstrated 
“excellent” absolute and ‘good’ to ‘high’ relative reproducibility (Table 4.). In the present study, 
[Pialk] was ~0.35 mM in the quadriceps of healthy young adults, which was two-fold higher than 
values reported in the quadriceps of obese individuals (~0.18 mM) (2), but within the range of 
values measured in untrained young adults at 7T (~0.28-0.42 mM)2,90. In contrast, Sedivy et al., 
(2020), reported substantially higher [Pialk] in the plantar flexor muscles of healthy older 
individuals (~0.8 mM) and patients with peripheral arterial disease (~3.0 mM) a 3T (91). The 
reason for this discrepancy is unclear but might originate from the different muscle investigated 
(quadriceps vs. plantar flexors), the age of the subjects (young vs. older adults), and the different 
TR used (1.5 s vs. 15 s in the study by Sedivy et al., 2020) which might result in greater overlap 
with the cytosolic Pi signal.  
It is noteworthy that despite the large differences in concentration between Pialk and the other 
metabolites (e.g., PCr was ~80 fold higher, Pi ~7 fold higher than Pi, and PDE ~4 fold higher than 
Pialk) the metrics of absolute and relative reproducibility were high, and importantly, within a close 
range from these well-resolved metabolites, thus supporting our hypothesis that Pialk can be 
robustly and reproducibly quantified. To put this in perspective with a well-characterized 
metabolite, studies conducted at 1.5T reported CVs for cytosolic Pi of 27% from consecutive 
measurements in the tibialis anterior muscle (TA) (92) and 14% when measured 2 months apart in 
the quadriceps (93). Other studies performed at 3T also reported CVs for cytosolic Pi of 15% in 
the tibialis anterior muscle with a 10-day test-retest design (94) and 8% in the plantar flexor 
muscles with a one-week test-retest design (95). Only two studies calculated the ICC of 31P 
metabolites and reported ICC values of 0.79 for cytosolic Pi in the plantar flexor muscles with 
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measurements performed 1 week apart (95) and an ICC of 0.14 for the cytosolic Pi in the 
quadriceps with measurements performed 2 months apart (93). 
Collectively, these findings suggest that Pialk can be reliably quantified in the quadriceps at 3T, 
with a reproducibility similar to other well-studied phosphate metabolites (PCr, Pi, PDE). 
Furthermore, a high ICC for Pialk confirm that the acquisition technique and processing tools 
employed here enable to reliably detect, with a high level of sensitivity, fine changes in this lower-
signal metabolites in the skeletal muscle at 3T. Such finding is crucial for the longitudinal 
assessment of Pialk in the context of interventional studies and the long-term prospect of using this 
metabolite as a biomarker of mitochondrial content. 
5.2 Technical consideration for the measurement of Pialk 
Several aspects need to be considered to optimize the spectral resolution and reproducibility 
of Pialk. Indeed, Pialk quantification benefits from fast repetition rates (i.e., repetition times [TR]) 
due to its short T1 relaxation time relative to cytosolic Pi. Using a progressive saturation technique, 
the apparent T1 of Pialk was 412 ± 112 ms in the present study at 3T. This short apparent T1 was 
also consistent with a maximal signal intensity for a nominal flip angle of 80 degrees under fast 
pulsing conditions (Figure 16). The value estimated in the present study is also in agreement with 
the T1 of the alkaline Pi resonance measured in isolated mitochondria (T1 = 0.54 secs (16); T1 = 
0.60 secs (8)) and perfused liver (T1 = 0.71 (14)) at ultra-high magnetic field (9.4 T); although 
slightly longer apparent T1 (1.4 ± 0.5 s) have been reported in the skeletal muscle at 7T (3). 
Previous studies in humans used longer TRs (4-5 s (3, 19) and 15 s (2,91,96)) resulting in greater 
saturation of the cytosolic Pi, and thus greater overlap in the signal of the two Pi pools (Figure 
15B). In addition, the faster pulsing conditions used in the present study allowed more signal 
averaging to improve the SNR without leading to unreasonably long acquisition time (acquisition 
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time ~5 min in the present study). Finally, the prolonged irradiation (250 ms, Figure 17) of the 1H 
coupled to 31P using a decoupling pulse Waltz-4 available on most clinical MR scanners improved 
the signal intensity and spectral resolution of the Pialk peak. Such enhancement in the signal has 
previously been demonstrated to improve the repeatability of metabolite measurements (97). 
Together, the optimization of these acquisition parameters contributed to the high reproducibility 
of Pialk despite its low concentration and small chemical shift difference with Picyt.  
5.2 Measurement Reproducibility of high energy phosphate metabolites  
5.2.1 Effect of coil location in Pialk quantification 
When the coil position was moved on the thigh in the distal to proximal direction, the 
between-site CV for Pialk was 21.1% (Table 6), whereas PCr (CV: 4.6%) and Pi (CV: 8.1%) were 
only marginally affected. Interestingly, when sites 1 and 2, which displayed higher concentration 
of Pialk than other sites, were excluded from the analysis, the CV for Pialk decreased to 7.9%. 
Conceptually, the greater Pialk in those distal sites can originate from different muscle fiber 
properties in the sampled region (97) or change in coil loading/shimming quality.      
A recent study by Horwath et al., (2021) reported no differences in fiber type along the 
longitudinal orientation of the vastus lateralis using muscle biopsies thus ruling out any effect of 
muscle fiber typology on the present findings. The effect of coil location on the PCr recovery time 
constant, an index of mitochondrial function, is however more controversial with some studies 
documenting shorter PCr recovery in the proximal region of the tibialis anterior (98,99), whereas 
no difference was observed in the vastus lateralis (100).  
Although the total phosphate content of the spectra did not vary across sites, the FWHM 
of PCr, i.e., the homogeneity of the magnetic field in the sampled area, was higher at Sites 1 and 
2 compared to other sites (Figure 25.). This larger linewidth may have resulted in an overlap with 
 
 73 
the cytosolic Pi signal and thus Pialk signal overestimation during spectral fitting. In contrast, other 
well-resolved and higher-signal magnitude metabolites (PCr, PiCyt, ATP) would be less susceptible 
to such a small decrease in shimming quality as indicated by their unchanged concentration.    
 The measurement variability from coil positioning in the present study underscores the 
importance of coil placement for Pialk quantification. Accordingly, additional data will be collected 
to provide further guidance on the location placement for adequate magnetic field homogeneity 
along the length of the thigh when measuring Pialk in the quadriceps. Alternative strategies will be 
to use localized sequences (e.g., ISIS, PRESS) for high homogeneity in the region of interest. 
5.2.2 Effect of repeated shimming on Pialk quantification  
In accordance with our initial hypothesis, 10 consecutive scans performed on the same 
participant with the coil placed at mid-thigh resulted in ‘excellent’ absolute reproducibility for 
Pialk (CV: 2.3 %, Table 6), which was of similar magnitude as the CVs for PCr (CV: 1.5%), Pi 
(CV: 3.0%), PDE (CV: 1.7%), and pH (CV: 0.1-0.3%). These CVs, including Pialk, are actually 
lower than values previously reported in the skeletal muscle by other 31P studies at lower magnetic 
field (1.5T) (92,93). Besides differences in magnetic field, manual shimming was performed after 
the automatic localized map shimming procedure to lower PCr FWHM below 15 Hz, which likely 
contributed to better spectral resolution and more consistent quantification. 
5.2.3 Effect of spectral processing and quantification on Pialk and phosphate metabolites 
reproducibility  
Using a time-domain fitting routine and the AMARES algorithm (81), with the same prior 
knowledge for the metabolites of interest, incorporated into the CSIAPO software (82), the 
quantification of all major phosphate metabolites was extremely reproducible (‘excellent’) with 
CVs below 1%, reaching 2.3% for Pialk. These values are in line with Layec et al., (2009) and 
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superior to the study by Miller et al. (1995), which relied on a manual curve fitting program thus 
more prone to quantification error. Despite the low concentration and close spectral proximity with 
the cytosolic Pi, the quantification of Pialk was highly reproducible in the present experimental 
consideration, which confirm the robustness of the present automated processing by CSIAPO in 
quantifying this 31P-MRS-derived metabolite. 
5.3 Perspectives 
Collectively, an ‘excellent absolute’, and for most markers, ‘good’ relative, reproducibility 
suggests that these measurements are sensitive to both (1) changes over longitudinal periods and 
(2) between-subjects. The present findings of high Pialk reproducibility in a sample of healthy 
young adults supports the application of this technique in detecting Pialk in different populations 
and across treatment/therapeutic interventions. Whether the quantification and reproducibility of 
Pialk extends to different population groups, characterized by distinct clinical profiles, remains to 
be investigated if Pialk is proven to be related to mitochondrial content. Reproducibly quantifying 
Pialk at 3T in a clinical setting is thus promising and warrants future investigation. 
Pialk is a promising surrogate biomarker of mitochondrial content. Thus, the quantification 
of Pialk should be sensitive to fiber-type distribution between different muscles (gastrocnemius vs. 
soleus (3)). The present study, however, was limited to scans conducted on the belly of the rectus 
femoris, which is characterized by a mixed fiber typology. Given that we were able to reliably 
quantify Pialk across seven days, it is noteworthy to explore the capability of our present MR study 
design to capture changes in Pialk muscles of differing fiber type compositions. 
A final experimental consideration of the present study is the duration of the test-retest design: 
seven days. Although excellent reproducibility was detected across all metabolites and conditions, 
this raises the question if the same would apply to longer longitudinal interventions. For example, 
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Layec et al, (2009) revealed ‘very poor’ relative reproducibility, as assessed by ICC, for PCr, Pi, 
PDE, and pH in their two-month test-retest design. Further, absolute reproducibility of smaller 
peak phosphates was modest (CV: 10-15%) for resonances like Pi. The higher spectral resolution 
of the present 3T magnet (as compared to 1.5T in Layec et al., 2009) most likely contributed to 
the higher reproducibility of the present study. However, whether longer duration between tests, 
as is common for therapeutic monitoring in clinical conditions, may hinder Pialk reproducibility 
remains to be explored. 
5.4 Conclusion 
The present study revealed that Pialk demonstrated an excellent seven-day absolute and relative 
reproducibility, similar to larger phosphate metabolites (e.g. PCr). This finding is a pre-requisite 
for Pialk to be sensitive to both longitudinal changes (i.e., within-subjects) and cross-sectional 
analysis (i.e., between-subject changes). An important aspect to consider is the placement of the 
surface coil and sufficient shimming quality. Specifically, sites most distal to the rectus femoris, 
associated with lower magnetic field homogeneity in the region of interest, demonstrated 
artificially higher Pialk concentrations likely caused by greater overlap between Pialk and Picyt and 
resulting in this overestimation. Comparison with prior literature also suggest a benefit of 
combining automatic and manual shimming of the signal for optimization of Pialk linewidth 
(FWHM < 15Hz) and more accurate quantification. Provided that sufficient shimming quality is 
achieved, the quantification of Pialk using fitting algorithm such as AMARES yield to highly 
reproducible results. 
Collectively, the present results improve our understanding of the reproducibility of 31P-MRS-
derived markers by revealing excellent absolute and relative reproducibility across a wide-range 
of conditions (e.g., test-retest, spectral processing, measurement procedure, etc.). These results add 
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to a limited literature investigating the reproducibility of 31P-MRS. Importantly, Pialk, a novel 
surrogate of mitochondrial content, was also highly reproducible, validating the application of this 
biomarker in research and clinical settings. Future studies are still needed to elucidate the 
reproducibility of Pialk across longer test-retest conditions (e.g., >7 days) and in clinical 
populations (e.g., older adults). This is important given that the application of Pialk quantification 
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